The Lancet Microbe
Q1 Journal
Open Access
Journal
Country
United Kingdom
Western Europe
Subject Area and Category
Immunology and Microbiology
└
Infectious Diseases
Q1
└
Microbiology
Q1
└
Microbiology (medical)
Q1
Publisher
SJR 2025
5.192
Q1
SJR Score
H-Index
67
Citations / Doc (2yr)
9.54
Total Docs. (latest)
246
Total Citations (3yr)
5,071
Publication type
Journals
ISSN
26665247
Coverage
2020-2026
Journal Rank
#269
Subject Categories
Infectious Diseases
Q1
Microbiology
Q1
Microbiology (medical)
Q1
Virology
Q1
Subject Areas
Aims & Scope
The Lancet Microbe publishes clinically relevant microbes at all scales—from the nature of the microbe (eg, antimicrobial resistance genes/plasmids, virulence factors) to the microbiome, to pathology (including immunology) to population level effects (eg, outbreaks, epidemiology).
We also publish early phase clinical trials and other interventional studies where the outcomes are focused on the pathogen.
The journal also continues in the The Lancet's tradition of being a strong advocate for and collaborator with the community we serve.
We publish a range of content types including Articles, Comment, Correspondence, Newsdesk, and Personal View.
Abstracting & Indexing
Scopus
Google Scholar
Directory of Open Access Journals (DOAJ)
Web of Science
Medline
Detailed Metrics
| Total Docs. (latest) | 246 |
| Total Docs. (3 years) | 556 |
| Total Refs. | 6,902 |
| Total Citations (3 years) | 5,071 |
| Citable Docs. (3 years) | 287 |
| Citations / Doc. (2 years) | 9.54 |
| Ref. / Doc. | 28.06 |
| % Female | 44.5% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.